InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
9
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Gold Mitchell. Director active across 3 companies, notably ALPINE IMMUNE SCIENCES, INC.. Aggregated, 16 disclosures have been recorded. Breakdown: 0 buy · 9 sells. Total volume traded: €5.9m. History available since 12 May 2021. The latest transaction was disclosed on 8 May 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gold Mitchell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
2,627,157 sharesCommon StockSEC:0001626199-24-000092:0
13,245 shares@ US$7.553.5% of flowCommon StockSEC:0001626199-24-000073:0
96,000 shares0Common StockSEC:0001626199-24-000025:0
1,016 shares@ US$0.650.0% of flowCommon StockSEC:0001626199-23-000149:0
37,825 shares@ US$0.450.6% of flowCommon StockSEC:0001626199-23-000147:0
2,402 shares@ US$0.450.0% of flowCommon StockSEC:0001626199-23-000144:0
8,613 shares@ US$0.450.1% of flowCommon StockSEC:0001626199-23-000134:3
8,067 shares@ US$17.07994.8% of flowCommon StockSEC:0001626199-23-000134:0
68,870 shares@ US$17.264841.9% of flowCommon StockSEC:0001626199-23-000134:1
32,450 shares@ US$17.315519.8% of flowCommon StockSEC:0001626199-23-000134:2
8,613 shares@ US$17.31555.3% of flowCommon StockSEC:0001626199-23-000134:4
400,000 shares@ US$9.4079.3% of flowCommon StockSEC:0001626199-21-000115:0
3,484 shares@ US$10.000.7% of flowCommon StockSEC:0001626199-21-000109:0
9,473 shares@ US$10.01432.0% of flowCommon StockSEC:0001626199-21-000087:0
50,965 shares@ US$15.028315.6% of flowCommon StockSEC:0001626199-21-000078:0
10,000 shares@ US$11.68422.4% of flowCommon StockSEC:0001626199-21-000072:0
16 of 16 declarations
About Gold Mitchell
GOLD MITCHELL is Executive Chairman and CEO at Alpine Immune Sciences, INC. and ALPINE IMMUNE SCIENCES, INC. The 16 filings on record are sales, with 5,922,699 EUR of sell volume across the most recent filings held, between 2021-05-14 and 2024-05-20.
